Histogen Inc. (HSTO)

Histogen Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Revenue	3.77	0.92	2.06	11.3	33.59
Revenue Growth (YoY)	310.12%	-55.37%	-81.79%	-66.34%	-5.06%
Cost of Revenue	0	0.22	0.97	2.22	0
Gross Profit	3.77	0.7	1.09	9.09	33.59
Selling, General & Admin	9.39	7.8	6.59	6.21	10.5
Research & Development	5.02	8.47	6.22	4.1	41.37
Other Operating Expenses	0	-0.11	0.11	-0.15	0
Operating Expenses	14.41	16.16	12.81	10.16	51.86
Operating Income	-10.64	-15.46	-11.71	0.91	-18.28
Interest Income	0	0	0	0.57	0.96
Interest Expense	0	0.01	-0.06	0	0.7
Other Expense / Income	-	-0.46	7.17	4.47	-0.96
Pretax Income	-10.64	-15.01	-18.82	-3	-18.01
Income Tax	-0.16	-0.6	6.96	1.9	0.96
Net Income	-10.48	-14.41	-25.77	-4.9	-18.01
Shares Outstanding (Basic)	3	2	0	1	3
Shares Outstanding (Diluted)	3	2	0	1	3
Shares Change	67.41%	325.39%	-23.66%	-80.55%	6.24%
EPS (Basic)	-3.26	-7.51	-57.16	-8.29	-5.93
EPS (Diluted)	-3.26	-7.51	-57.16	-8.29	-5.93
Free Cash Flow	-9.9	-14.77	-12.1	-1.44	-34.92
Free Cash Flow Per Share	-3.08	-7.70	-26.84	-2.44	-11.50
Gross Margin	100.00%	76.06%	52.99%	80.41%	100.00%
Operating Margin	-282.38%	-1681.94%	-568.92%	8.01%	-54.42%
Profit Margin	-278.08%	-1567.46%	-1251.77%	-43.33%	-53.62%
Free Cash Flow Margin	-262.64%	-1607.51%	-587.81%	-12.77%	-103.98%
EBITDA	-10.64	-15.45	-4.57	1.05	-17.22
EBITDA Margin	-282.38%	-1680.85%	-221.95%	9.29%	-51.28%
Depreciation & Amortization	0.14	0.1	0.1	0.15	0.09
EBIT	-10.78	-15.54	-4.67	0.91	-17.31
EBIT Margin	-286.10%	-1691.40%	-226.71%	8.01%	-51.55%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.